During cardiopulmonary resuscitation in an adult, at what rate are chest compressions given?
What is the maximum concentration of potassium that can be safely delivered via a central line?
The Acute Physiology and Chronic Health Evaluation (APACHE) scoring system is used for what purpose?
Which of the following components are included in the APACHE-II score?
A patient in the surgical ICU is in septic shock after surgery for perforated diverticulitis. His temperature is 102.3degF and his heart rate is 120 bpm. He is requiring dopamine for BP support. Which of the following drugs would be appropriate for use in this situation?
Intravenous potassium chloride should be administered how?
Which of the following is NOT included in the APACHE II score calculation?
A 28-year-old male with septic shock remains hypotensive despite adequate volume replacement; PA occlusion pressure is 18 mm Hg. Dopamine infusion leads to ventricular tachycardia unresponsive to lidocaine. The rhythm converts to sinus rhythm upon stopping dopamine. Which of the following treatments is most appropriate for this hypotensive patient?
Which of the following parameters is NOT included in the APACHE score?
In ARDS management, what is the usual tidal volume setting for mechanical ventilation?
Explanation: **Explanation:** The correct answer is **C. 100 compressions/min**. **Medical Concept:** According to the latest American Heart Association (AHA) and ERC guidelines for Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS), the recommended rate for chest compressions in adults is **100 to 120 compressions per minute**. High-quality CPR is essential to maintain coronary and cerebral perfusion. A rate of at least 100 bpm ensures sufficient cardiac output, while exceeding 120 bpm is discouraged as it reduces the time for ventricular filling and decreases the quality of recoil. **Analysis of Options:** * **A (72/min) & B (90/min):** These rates are too slow. Inadequate compression frequency fails to generate the necessary intrathoracic pressure and arterial perfusion pressure required to restart the heart or protect the brain. * **D (120/min):** While 120 is the upper limit of the recommended range, standard medical examinations (like NEET-PG) traditionally prioritize the baseline "at least 100/min" as the gold standard answer when a range is not provided. **High-Yield Clinical Pearls for NEET-PG:** * **Compression Depth:** 2 to 2.4 inches (5 to 6 cm) in adults. * **Compression-to-Ventilation Ratio:** 30:2 for adults (single or dual rescuer). * **Recoil:** Allow complete chest recoil after each compression to allow the heart to fill. * **Minimize Interruptions:** Keep pauses in compressions to less than 10 seconds. * **EtCO2 Monitoring:** A capnography reading of <10 mmHg during CPR indicates poor quality compressions.
Explanation: **Explanation:** The management of hypokalemia requires careful titration to avoid life-threatening arrhythmias and phlebitis. The concentration of potassium replacement is strictly governed by the route of administration and the urgency of the clinical situation. **Why 20 mmol/L is the correct answer:** While textbooks often cite different "maximums" based on clinical urgency, standard safety guidelines (such as those from the NHS and various critical care societies) recommend a standard concentration of **20 mmol/L** for routine replacement. Although higher concentrations (up to 40 mmol/L) can be infused via a central line in ICU settings under continuous ECG monitoring, 20 mmol/L is considered the safest standard concentration to prevent accidental bolus-induced cardiac arrest and to minimize the risk of hyperkalemia. **Analysis of Incorrect Options:** * **40 mmol/L:** This is typically the maximum concentration allowed for **peripheral** administration (though 10–20 mmol/L is preferred to avoid pain and phlebitis). While it can be given centrally, it is not the "standard" safe limit for routine replacement. * **60 mmol/L & 80 mmol/L:** These are highly concentrated solutions. They are reserved only for extreme, life-threatening hypokalemia in an ICU setting with a dedicated central venous catheter and constant cardiac monitoring. They are never used for routine safety protocols. **High-Yield Clinical Pearls for NEET-PG:** 1. **Rate of Infusion:** The standard rate of potassium replacement should not exceed **10 mmol/hour**. In emergency cases (e.g., paralysis or arrhythmias), it may be increased to **20 mmol/hour** with continuous ECG monitoring. 2. **Peripheral vs. Central:** Peripheral veins are sensitive; concentrations >40 mmol/L cause severe pain and chemical phlebitis. Central lines are preferred for higher concentrations due to rapid dilution in a high-flow vessel. 3. **The "Magnesium" Rule:** If hypokalemia is refractory to treatment, always check and correct **Magnesium** levels. Low magnesium inhibits potassium reabsorption in the kidneys. 4. **ECG Changes:** Remember the sequence—U waves and flattened T waves in hypokalemia; Tall peaked T waves and widened QRS in hyperkalemia.
Explanation: ### Explanation **1. Why Option C is Correct:** The **APACHE (Acute Physiology and Chronic Health Evaluation)** score is the most widely used severity-of-illness scoring system in Intensive Care Units (ICUs). It is designed to predict **hospital mortality** and evaluate prognosis by assessing the severity of a patient's physiological derangement. The score is calculated based on three components: * **Acute Physiology Score:** Based on the worst values of 12 physiological variables (e.g., heart rate, MAP, temperature, GCS, oxygenation) recorded during the first 24 hours of ICU admission. * **Age points:** Increasing age correlates with higher mortality. * **Chronic Health points:** Accounts for pre-existing organ dysfunction or immunocompromised states. A higher APACHE score correlates with a higher risk of hospital death. **2. Why Other Options are Incorrect:** * **Option A:** Postoperative cardiac risk is typically assessed using the **Revised Cardiac Risk Index (Lee’s Criteria)** or the **Goldman Index**. * **Option B:** Postoperative pulmonary complications are predicted using tools like the **ARISCAT (Canet) score** or the **STOP-BANG** questionnaire (for OSA). * **Option D:** Prognosis after acute myocardial infarction is specifically evaluated using the **Killip Classification** or the **TIMI Risk Score**. **3. High-Yield Clinical Pearls for NEET-PG:** * **APACHE II** is the most commonly used version in clinical practice and exams. * **Timing:** It is calculated using the **worst** physiological parameters within the **first 24 hours** of ICU admission. * **Other ICU Scores:** * **SOFA (Sequential Organ Failure Assessment):** Used to track organ dysfunction over time (unlike APACHE, which is a one-time snapshot). * **qSOFA:** Used for rapid bedside screening of sepsis (RR ≥22, Altered Mentation, SBP ≤100). * **Glasgow Coma Scale (GCS):** A component of the APACHE score used to assess neurological status.
Explanation: The **APACHE-II (Acute Physiology and Chronic Health Evaluation II)** score is one of the most widely used severity-of-disease classification systems in the ICU. It is calculated within the first 24 hours of admission to predict hospital mortality. ### **Explanation of the Correct Answer** The APACHE-II score is derived from the sum of three distinct components: 1. **Acute Physiology Score (APS):** This includes 12 physiological variables, including **Mean Arterial Pressure (Blood Pressure)** and **Respiratory Rate**. 2. **Age Points:** Points increase as the patient’s **Age** increases (starting from >44 years). 3. **Chronic Health Points:** Points added for severe organ failure or immunocompromised status. Since Age, Blood Pressure, and Respiratory Rate are all integral parts of the calculation, **Option D (All of the above)** is the correct answer. ### **Analysis of Components** * **Age (A):** A non-modifiable risk factor; older patients have less physiological reserve. * **Blood Pressure (B):** Specifically, the **Mean Arterial Pressure (MAP)** is used to assess hemodynamic stability. * **Respiratory Rate (C):** Used to assess ventilatory status and metabolic compensation. ### **High-Yield Clinical Pearls for NEET-PG** * **Timing:** APACHE-II is calculated using the **worst** values recorded during the **first 24 hours** of ICU admission. * **The 12 Physiological Variables:** MAP, Heart Rate, Respiratory Rate, Temperature, Oxygenation (FiO2/PaO2), Arterial pH, Serum Sodium, Potassium, Creatinine, Hematocrit, White Blood Cell Count, and **Glasgow Coma Scale (GCS)**. * **Interpretation:** A higher score (0–71) correlates with a higher risk of hospital death. * **Limitation:** It does not account for specific diagnoses as accurately as it does general physiological derangement.
Explanation: **Explanation:** The patient is presenting with **Septic Shock** (sepsis with hypotension requiring vasopressors). In severe sepsis and septic shock, there is a systemic inflammatory response coupled with a pro-coagulant state and impaired fibrinolysis, leading to microvascular thrombosis and organ failure. **1. Why Recombinant Activated Protein C (rhAPC) is correct:** Activated Protein C (Drotrecogin alfa) is an endogenous protein that exerts **antithrombotic, anti-inflammatory, and profibrinolytic** effects. It inhibits Factors Va and VIIIa, limiting thrombin generation. Historically, based on the PROWESS trial, it was the first biological agent shown to reduce mortality in patients with high-risk sepsis (APACHE II score ≥25 or multi-organ failure). *Note: While Drotrecogin alfa was withdrawn from the market globally in 2011 after the PROWESS-SHOCK trial failed to replicate mortality benefits, it remains a classic "high-yield" concept in medical examinations to test the pathophysiology of sepsis management.* **2. Why the other options are incorrect:** * **Options B, C, and D:** Anti-TNF antibodies (e.g., Infliximab), IL-1 receptor antagonists (e.g., Anakinra), and Anti-endotoxin antibodies (e.g., Edobacomab) have all been extensively studied in clinical trials. Despite their theoretical ability to neutralize inflammatory mediators, they have **failed to demonstrate a significant mortality benefit** in large-scale human trials for sepsis. **High-Yield Clinical Pearls for NEET-PG:** * **Sepsis-3 Definition:** Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (SOFA score increase ≥2). * **Septic Shock:** Sepsis requiring vasopressors to maintain MAP ≥65 mmHg AND Serum Lactate >2 mmol/L despite adequate fluid resuscitation. * **Drug of Choice:** The current first-line vasopressor for septic shock is **Norepinephrine**. * **Early Goal-Directed Therapy (EGDT):** Focuses on maintaining CVP (8–12 mmHg), MAP (≥65 mmHg), and ScvO2 (≥70%).
Explanation: **Explanation:** The administration of intravenous (IV) potassium chloride (KCl) requires strict adherence to safety protocols because rapid or concentrated infusion can lead to fatal cardiac arrhythmias or severe local tissue injury. **Why Option B is Correct:** Potassium chloride must always be **diluted** before administration. **Normal Saline (0.9% NaCl)** is the preferred vehicle. Dilution ensures that the concentration remains within safe limits (usually 40 mmol/L for peripheral lines and up to 100 mmol/L for central lines) to prevent phlebitis and cardiac toxicity. **Why Other Options are Incorrect:** * **Options A & D:** Administering KCl as a **bolus** (whether peripheral or central) is strictly contraindicated. A sudden surge in serum potassium levels can cause immediate cardiac arrest in diastole. * **Option C:** Diluting KCl in **5% Dextrose** is generally avoided during the initial correction of hypokalemia. Dextrose stimulates insulin release, which shifts potassium from the extracellular fluid into the cells. This can further drop the serum potassium levels initially, potentially worsening the patient's condition. **High-Yield Clinical Pearls for NEET-PG:** 1. **Maximum Rate:** In a stable patient, the infusion rate should not exceed **10–20 mmol/hour**. 2. **Monitoring:** Continuous ECG monitoring is mandatory if the infusion rate exceeds 10 mmol/hour. 3. **Concentration:** For peripheral veins, the concentration should not exceed **40 mmol/L** to avoid thrombophlebitis and pain. 4. **Refractory Hypokalemia:** If hypokalemia does not respond to KCl, always check **Magnesium levels**; hypomagnesemia often coexists and prevents effective potassium replacement.
Explanation: The **APACHE II (Acute Physiology and Chronic Health Evaluation II)** is a widely used severity-of-disease classification system in the ICU. It is designed to predict hospital mortality based on data collected within the first 24 hours of admission. ### Why "Sex" is the Correct Answer The APACHE II score is calculated based on three distinct components: **Acute Physiology Score (APS)**, **Age**, and **Chronic Health Evaluation**. **Sex (Gender)** is not a variable in the APACHE II scoring system. While gender may influence outcomes in certain diseases, it was not found to be a statistically significant independent predictor of mortality when the APACHE II model was validated. ### Explanation of Incorrect Options * **Acute Physiology Score (A):** This is the core component, consisting of 12 physiological variables (e.g., Heart rate, Mean Arterial Pressure, Temperature, Respiratory rate, Oxygenation, pH, Sodium, Potassium, Creatinine, Hematocrit, White blood cell count, and Glasgow Coma Scale). * **Age (B):** Increasing age is strongly correlated with higher mortality; points are added for patients over 44 years old, with the maximum points given to those ≥75. * **Chronic Health Evaluation (D):** Points are added if the patient has a history of severe organ insufficiency (Heart, Liver, Lung, Renal) or is immunocompromised. ### High-Yield Facts for NEET-PG * **Range:** The total score ranges from **0 to 71**. Higher scores correlate with a higher risk of hospital death. * **Timing:** Data must be collected within the **first 24 hours** of ICU admission. * **GCS:** The Glasgow Coma Scale is the only neurological component included. * **Creatinine:** In cases of **Acute Renal Failure**, the points for the Serum Creatinine level are **doubled**. * **Limitation:** APACHE II predicts *group* mortality rather than individual outcomes and does not account for specific diagnoses as accurately as newer versions (like APACHE IV).
Explanation: **Explanation:** The patient is in **septic shock** (distributive shock) characterized by profound vasodilation. Despite adequate fluid resuscitation (indicated by a PAOP of 18 mm Hg), he remains hypotensive. The development of dopamine-induced ventricular tachycardia indicates **myocardial irritability** and an inability to tolerate beta-1 adrenergic stimulation. **Why Phenylephrine is the Correct Choice:** Phenylephrine is a **pure alpha-1 adrenergic agonist**. It causes systemic vasoconstriction, increasing Systemic Vascular Resistance (SVR) and blood pressure without stimulating beta receptors. Since the patient has already demonstrated life-threatening arrhythmias (VT) with dopamine, a drug that lacks beta-mimetic activity is the safest and most appropriate choice to maintain perfusion pressure without triggering further tachyarrhythmias. **Analysis of Incorrect Options:** * **Amrinone:** A phosphodiesterase-3 inhibitor that acts as an "inodilator." It causes peripheral vasodilation, which would worsen hypotension in a septic patient. * **Dobutamine:** Primarily a beta-1 agonist with some beta-2 activity. It would likely exacerbate the ventricular irritability and cause further vasodilation, worsening the shock state. * **Epinephrine:** A potent alpha and beta agonist. Its strong beta-1 activity would carry a high risk of recurring ventricular tachycardia in this specific patient. **High-Yield Clinical Pearls for NEET-PG:** * **Septic Shock Definition:** Hypotension requiring vasopressors to maintain MAP ≥65 mmHg and serum lactate >2 mmol/L despite adequate fluid resuscitation. * **First-line Vasopressor:** In standard septic shock, **Norepinephrine** is the first-line agent. * **Phenylephrine Indications:** Useful when norepinephrine causes serious arrhythmias or when cardiac output is high but blood pressure remains low. * **PAOP (Pulmonary Artery Occlusion Pressure):** Normal is 8–12 mm Hg. A value of 18 mm Hg suggests the patient is "filled" and hypotension is not due to hypovolemia.
Explanation: The **APACHE II (Acute Physiology and Chronic Health Evaluation II)** score is a widely used severity-of-disease classification system in the ICU. It is calculated within the first 24 hours of admission to predict hospital mortality. ### Why Serum Bilirubin is the Correct Answer **Serum Bilirubin** is notably **absent** from the APACHE II scoring system. While bilirubin is a key component of other scoring systems like the **SOFA (Sequential Organ Failure Assessment)** and **Child-Pugh** scores (to assess liver dysfunction), APACHE II focuses primarily on acute physiological derangements, age, and chronic health status without specific laboratory markers for hepatic function. ### Explanation of Incorrect Options * **Glasgow Coma Scale (GCS):** This is a vital component of the "Acute Physiology Score" section of APACHE II, used to assess the neurological status of the patient. * **pH of Blood:** Arterial pH (or serum bicarbonate if ABG is unavailable) is included to evaluate the acid-base balance and metabolic/respiratory distress. * **Age of Patient:** Age is a core independent variable in APACHE II because physiological reserve decreases with age, directly correlating with increased mortality risk. ### High-Yield Facts for NEET-PG * **Components of APACHE II:** It consists of 12 physiological variables (including Temp, MAP, Heart Rate, Respiratory Rate, Oxygenation, pH, Sodium, Potassium, Creatinine, Hematocrit, WBC count, and GCS) + Age + Chronic Health points. * **SOFA vs. APACHE:** If a question asks about **liver function** or **platelet count**, think **SOFA**. If it asks about **chronic health** and **age**, think **APACHE**. * **Timing:** APACHE II is calculated using the **worst** values recorded during the first 24 hours of ICU admission. * **Limitations:** It cannot be used to predict individual survival; it is designed for group mortality risk and quality of care benchmarking.
Explanation: **Explanation:** The cornerstone of managing **Acute Respiratory Distress Syndrome (ARDS)** is **Lung Protective Ventilation (LPV)**. In ARDS, the lungs are heterogeneously affected, with significant areas of consolidation and collapse, leaving only a small portion of functional, aerated lung—a concept known as the **"Baby Lung."** **1. Why 5-7 ml/kg is correct:** Standard tidal volumes (10-12 ml/kg) can cause **Volutrauma** (overdistension) and **Biotrauma** (inflammatory release) in the remaining functional lung units. The ARDSNet protocol recommends a low tidal volume strategy, typically starting at **6 ml/kg of Predicted Body Weight (PBW)**, with a range of **5-8 ml/kg** (most closely represented by option B). This reduces mortality by preventing ventilator-associated lung injury (VALI). **2. Why other options are incorrect:** * **A (2-3 ml/kg):** This is excessively low and would lead to severe hypercapnia and significant atelectasis, making it impossible to maintain adequate minute ventilation. * **C (5-10 ml/kg):** While it starts correctly, the upper limit (10 ml/kg) is too high for ARDS and risks barotrauma. * **D (12-14 ml/kg):** These are traditional high tidal volumes used decades ago, now known to increase mortality in ARDS patients. **High-Yield Clinical Pearls for NEET-PG:** * **PBW vs. Actual Weight:** Tidal volume is always calculated based on **Predicted Body Weight** (based on height and sex), not actual weight, because lung size does not increase with obesity. * **Plateau Pressure ($P_{plat}$):** The goal is to keep $P_{plat}$ **< 30 cm $H_2O$**. * **Permissive Hypercapnia:** To maintain low tidal volumes, clinicians may allow $PaCO_2$ to rise and pH to drop (up to 7.20), provided the patient tolerates it. * **Driving Pressure:** Calculated as ($P_{plat} - PEEP$); keeping this **< 15 cm $H_2O$** is a strong predictor of survival.
Applied Respiratory Physiology
Practice Questions
Mechanical Ventilation Principles
Practice Questions
Ventilator Management Strategies
Practice Questions
Acute Respiratory Distress Syndrome
Practice Questions
Shock: Classification and Management
Practice Questions
Hemodynamic Monitoring in ICU
Practice Questions
Acid-Base Disorders
Practice Questions
Fluid and Electrolyte Management
Practice Questions
Sedation and Analgesia in ICU
Practice Questions
Neurocritical Care
Practice Questions
Renal Replacement Therapy
Practice Questions
Nutrition in Critical Illness
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free